In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2

MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a

(2011) Sara Toffanin et al.   GASTROENTEROLOGY

Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome

(2011) Angela Di Vinci et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells

(2010) Francesca Fornari et al.   CANCER RESEARCH

Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells

(2010) Kuo-Wang Tsai et al.   Epigenetics

Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response

(2010) Ornella Cazzalini et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

The Akt isoforms are present at distinct subcellular locations

(2009) Stacey A. Santi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

(2009) Michela Garofalo et al.   CANCER CELL

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9

(2009) Jing-song Chen et al.   HEPATOLOGY RESEARCH

Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

(2008) Augusto Villanueva et al.   GASTROENTEROLOGY

MicroRNA involvement in hepatocellular carcinoma

(2008) Laura Gramantieri et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma

(2008) Anne-Christine Piguet et al.   JOURNAL OF HEPATOLOGY

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

(2008) F Fornari et al.   ONCOGENE